Clinical, Immunological and Microbiological Improvements With Zinc-Coated Healing Abutments During the Healing Phase.

What Was Tested

This clinical trial looks at Vitamin D, K2, Magnesium and Zinc.

The aim of this study was to evaluate the clinical, immunological, and microbiological effects of zinc-coated healing abutments (Zn-TiO2 abutments) on peri-implant soft tissue as compared with the commercially used ones (Ti abutments).

Who Took Part

By PubMed's age tags, the people studied were middle-aged adults, both men and women.

The Ti and Zn-TiO2 abutments were non-randomly connected to 2 neighbouring implants in the posterior region in each eligible patient.

How the Study Was Run

In design terms this was an open-label study.

Everyone knew when Vitamin D, K2, Magnesium and Zinc was being given (open label), which is simpler to run but leaves more room for expectations to affect what is reported.

The study was a prospective, non-randomised, single-centre, open-label, proof-of-concept clinical trial.

The bleeding-on-probing proportion (BOP%), probing pocket depth (PPD), the concentration of the pro-inflammatory cytokine (TNF-α, IL-6) in the peri-implant crevicular fluid (PICF), and the early microbial communities assessed by 16S rRNA sequencing were recorded.

What Was Measured

The subject headings attached to it are Dental Abutments, Zinc, Gingival Crevicular Fluid, Titanium, Tumor Necrosis Factor-alpha, Interleukin-6 and Dental Implants.

Author keywords: Clinical outcomes, Implant healing abutments, Microbiome, Pro-inflammatory cytokines and Zinc coatings.

What This Means in Plain Language

The paper is an open-label study of Vitamin D, K2, Magnesium and Zinc.

The abstract goes on to report its results in about 7 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2026 (International dental journal), a journal based in England.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.